As of May 7, 2024, the Healthequity stock's price-to-earnings ratio is 123.66. This results from the current EPS of $0.65 and stock price of $80.38.
The PE ratio of Healthequity has averaged 663.21 over the last ten years. The current P/E ratio of 123.66 is 81% lower than the historical average. In the past ten years, HQY's PE ratio peaked in the Jul 2021 quarter at 7,398, when the stock price was $73.98 and the EPS was $0.01. The lowest point was in the Apr 2019 quarter, when it reached 45.17 with a price of $67.75 and an EPS of $1.5.
Maximum annual increase: 521.82% in 2021
Maximum annual decrease: -37.65% in 2018
| Year | PE ratio | Change |
|---|---|---|
| 2024 | 116.28 | N/A |
| 2023 | N/A | N/A |
| 2022 | N/A | N/A |
| 2021 | 696.25 | 521.82% |
| 2020 | 111.97 | 115.53% |
| 2019 | 51.95 | -18.93% |
| 2018 | 64.08 | -37.65% |
| 2017 | 102.78 | 38.31% |
| 2016 | 74.31 | 39.52% |
| 2015 | 53.26 | N/A |
The current PE ratio of HQY is lower than the 5-year average.
In comparison to its peer stocks UHAL and EZPW, HQY's PE ratio is higher.
| Stock name | PE ratio | Market cap |
|---|---|---|
| EZPW Ezcorp Inc | 7.31 | $570.3M |
| UHAL Amerco | 16.45 | $13.38B |
| HQY Healthequity Inc | 123.66 | $6.93B |
HQY's price to earnings ratio is 123.66 as of May 7, 2024.
Over the last 5 years, the average price to earnings ratio for HQY stock is 1610.59.
In the last ten years, the Jul 2021 quarter recorded the highest quarterly PE ratio at 7,398.
HQY's price to earnings ratio is currently 81% below its 10-year historical average.
HQY's PE ratio is high because the stock price is relatively expensive compared to the earnings generated by the company.
To determine the P/E ratio, divide the latest stock price by the TTM earnings per share (EPS). As of today (May 7, 2024), Healthequity's stock price is $80.38. The earnings per share for the trailing twelve months (TTM) ending Jan 2024 is $0.65. Therefore, Healthequity's PE ratio for today is 123.66. PE RATIO(123.66) = STOCK PRICE($80.38) / TTM EPS($0.65)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.